ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
MorphoSys and I-Mab Announce FDA Clearance of IND Application for MOR210/TJ210 in Patients with Advanced Cancer
September 18, 2020MorphoSys AG and I-Mab jointly announced that the U.S. Food and Drug Administration (FDA) has cleared the Investigational New Drug application (IND) for MorphoSys' investigational human anti-C5aR1 antibody MOR210/TJ210 for the treatment of relapsed or ...
Pharma Sources Insight January 2025
